ON! Nicotine Pouches: Ownership, Product Lines & U.S. FDA Status
A sourced guide to ON! ownership, on! versus on! PLUS, the six on! PLUS products authorized for U.S. marketing, and where to check current SnusFriend catalogue status.
Quick answer.
ON! and on! PLUS are commercialized through Helix Innovations, an Altria operating company. Altria identifies Helix Innovations as its operating company. FDA's authorized nicotine pouch list identifies the six specific on! PLUS products authorized for U.S. marketing; that authorization is not FDA approval and does not establish availability outside the United States.
Who owns ON!?
Altria announced an agreement to acquire 80% of the relevant global on! business in 2019. Altria says transactions for the remaining 20% closed in December 2020 and April 2021, and that on! and on! PLUS are commercialized through Helix Innovations. Altria documents those ownership and commercialization statements.
The FDA marketing-order appendix identifies U.S. Smokeless Tobacco Company LLC as the product manufacturer for the six ordered products. Read the FDA marketing-order appendix.
on! and on! PLUS are distinct product families.
Altria Science describes on! PLUS as using proprietary NICOSILK mesh for product comfort. Read Altria Science's modern oral nicotine pouch overview. This attributed description does not establish composition, delivery performance, or a comparison with another product.
Six U.S.-authorized on! PLUS products.
FDA authorization dated 2025-12-19 covers six specific on! PLUS products for U.S. marketing: Mint 6 mg, Mint 9 mg, Tobacco 6 mg, Tobacco 9 mg, Wintergreen 6 mg, and Wintergreen 9 mg. The FDA public nicotine pouch list identifies the authorized products, and the marketing-order appendix records the ordered products.
What FDA authorization means and does not mean.
FDA authorization applies only to the specified U.S. products. It is not FDA approval or a safety finding, and it does not authorize modified-risk claims. FDA's public list explains that authorization to market a tobacco product does not mean the product is safe or FDA approved, and the marketing-order appendix records the ordered products. It does not establish safety or availability outside the United States.
Where to check current SnusFriend catalogue status.
For current SnusFriend catalogue status, consult the live ON! brand page. Catalogue status can change, and this article does not establish country-level availability, shipping, or legal status.
Five visible FAQs.
Who owns and commercializes ON!?
ON! and on! PLUS are commercialized by Helix Innovations, an Altria operating company. Altria completed its acquisition of the global on! business through transactions that closed in 2020 and 2021.
Which on! PLUS products are authorized for U.S. marketing?
FDA's current list names six on! PLUS products: Mint, Tobacco, and Wintergreen, each in 6 mg and 9 mg strengths. The authorization applies to U.S. marketing of those specific products.
Is FDA marketing authorization the same as FDA approval?
No. FDA states that authorization to market a tobacco product does not mean the product is safe or FDA approved.
Does U.S. authorization establish ON! availability outside the United States?
No. U.S. FDA marketing authorization applies only to the specified products in the United States. For current SnusFriend catalogue status, consult the live ON! brand page; this article does not establish country-level availability, shipping, or legal status.
What is NICOSILK?
Altria Science describes on! PLUS as using proprietary NICOSILK mesh for product comfort. This source does not establish a quantified delivery-speed claim or silk-based composition.
Primary sources.
This article is for informational purposes only and does not constitute medical advice. Nicotine is an addictive substance. If you have health concerns about nicotine use, consult a qualified healthcare professional.